Last reviewed · How we verify
Norgestimate; Ethinyl Estradiol; Folic acid
Norgestimate; Ethinyl Estradiol; Folic acid is a Small molecule drug developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.. It is currently in Phase 1 development.
At a glance
| Generic name | Norgestimate; Ethinyl Estradiol; Folic acid |
|---|---|
| Sponsor | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Folate Levels in Women Taking Oral Contraceptives (PHASE3)
- Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (PHASE1)
- A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM) /Ethinyl Estradiol (EE) in Healthy Women. (PHASE1)
- Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. (PHASE1)
- A Drug Interaction Study of Folic Acid and Oral Contraceptive Tablets Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) in Healthy Women. (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Norgestimate; Ethinyl Estradiol; Folic acid CI brief — competitive landscape report
- Norgestimate; Ethinyl Estradiol; Folic acid updates RSS · CI watch RSS
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. portfolio CI
Frequently asked questions about Norgestimate; Ethinyl Estradiol; Folic acid
What is Norgestimate; Ethinyl Estradiol; Folic acid?
Norgestimate; Ethinyl Estradiol; Folic acid is a Small molecule drug developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C..
Who makes Norgestimate; Ethinyl Estradiol; Folic acid?
Norgestimate; Ethinyl Estradiol; Folic acid is developed by Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (see full Johnson & Johnson Pharmaceutical Research & Development, L.L.C. pipeline at /company/johnson-johnson-pharmaceutical-research-development-l-l-c).
What development phase is Norgestimate; Ethinyl Estradiol; Folic acid in?
Norgestimate; Ethinyl Estradiol; Folic acid is in Phase 1.